Fwd: IRVINE--- Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in ...

---------- Forwarded message ----------
From: Search for lung cancer <rssfwd@rssfwd.com>
Date: Wed, Mar 26, 2008 at 2:45 PM
Subject: IRVINE--- Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in ...
To: mesothelioma77@gmail.com

NuRx Pharmaceutical Inc.'s next-generation rexinoid agonist, NRX4204, significantly reduced the number and size of lung tumors and lowered the total tumor volume in mouse models compared to the control group, ...

Wed, 26 Mar 2008 16:32:05 GMT

---

Source: http://www.freshnews.com/news/orange-county/article_42672.html
--
 Powered by RssFwd, a service of Blue Sky Factory, Inc